Tata Chemicals Q4 FY26 loss widens, sales down 2% YoY

Tata Chemicals results: what the market reacted to

Tata Chemicals, part of the Chemicals sector and Fertilizers industry, reported a sharp deterioration in its Q4 FY26 bottom line even as consolidated net sales for the March 2026 quarter edged lower. A results update dated May 5, 2026 said consolidated net sales stood at Rs 3,438 crore, down 2.02% year-on-year (YoY). The same update said the company’s consolidated net loss widened to Rs 2,132 crore in Q4 FY26 compared with a net loss of Rs 74 crore in Q4 FY25. The reported loss was accompanied by significant exceptional charges booked during the quarter.

Consolidated net sales: Rs 3,438 crore for March 2026 quarter

The company’s consolidated net sales for the March 2026 quarter were reported at Rs 3,438 crore. The YoY decline of 2.02% indicates a relatively modest drop at the top line, but the earnings outcome was dominated by non-operating items and exceptional charges. The market’s focus, based on the updates provided, remained on the extent of the quarterly loss and what drove it.

Q4 FY26 net loss widens sharply

The key headline from the May 5, 2026 update was the widening of the consolidated net loss to Rs 2,132 crore in Q4 FY26. This was compared against a consolidated net loss of Rs 74 crore in Q4 FY25. In the same update, Tata Chemicals reported a loss before exceptional items and tax of Rs 178 crore for Q4 FY26, versus a loss before exceptional items and tax of Rs 61 crore in Q4 FY25. That gap shows the underlying quarter was loss-making even before exceptional items, but the scale of the reported net loss was largely explained by exceptional charges.

Exceptional charges: US goodwill impairment and tax asset write-off

During the quarter, Tata Chemicals recorded an exceptional charge of Rs 1,837 crore on account of impairment of goodwill in the US. It also recorded Rs 159 crore related to a deferred tax assets write-off. Together, these items were highlighted as exceptional charges during Q4 FY26. The presence of these charges is central to understanding why the reported consolidated net loss moved far beyond the pre-exceptional loss figure.

Full-year FY26 swings to loss from profit in FY25

On a full-year basis, the company reported a consolidated net loss of Rs 1,715 crore in FY26. This compared with a consolidated net profit of Rs 387 crore in FY25. The year-level change indicates that FY26 earnings were pressured beyond a single quarter, with Q4 FY26 contributing a large portion of the full-year loss.

Stock movement after the results and later price snapshots

Following the Q4 FY26 earnings update, Tata Chemicals fell 1.56% to Rs 792.30, according to the report. A separate market snapshot in the provided text showed the stock at 750.20, down 4.90 or 0.65%, as of May 22, 2026 at 03:57. Another “share price update” section said Tata Chemicals moved down 0.57% from its previous close of Rs 650.45, with the stock last traded at Rs 646.75.

These price points are from different moments referenced in the supplied material, but they show that the market response around earnings and subsequent sessions remained cautious.

Results snapshot also cited EBITDA and PAT figures

A “performance highlights” block in the provided content listed additional quarterly metrics. It cited consolidated revenue from operations at Rs 3,438 crore, consolidated EBITDA at Rs 274 crore, and consolidated PAT at Rs (279) crore for Q4 FY25-26. The same block cited standalone revenue from operations at Rs 1,254 crore, standalone EBITDA at Rs 216 crore, and standalone PAT at Rs 48 crore.

These figures were presented as a snapshot alongside the Q4 commentary and are reproduced here as stated in the input.

Background: Q4 FY24 losses and the role of exceptional items

Tata Chemicals has faced sizable exceptional items in recent years as well. In reports relating to the quarter ended March 31, 2024 (Q4 FY24), the company was described as having posted a net loss of Rs 818 crore, with another update referencing losses from continuing operations at Rs 827 crore and other figures in the Rs 818-850 crore range. Those reports attributed the weak quarter to lower income and provisions for exceptional items, particularly in the UK business.

The same set of reports cited exceptional losses of Rs 963 crore in the UK business for Q4 FY24. They also detailed that the exceptional loss included non-cash write-downs, including property, plant and equipment of Rs 821 crore, capital work-in-progress of Rs 122 crore, right-of-use assets of Rs 4 crore, and other assets (net) of Rs 16 crore, relating to UK group operations.

Analyst view (historical): Kotak Institutional Equities rating

The provided content also referenced a historical note from Kotak Institutional Equities (KIE), which recommended a ‘sell’ rating on Tata Chemicals with a target price of Rs 770. The note said earnings were weak in 4QFY24 amid pricing pressure on soda ash across geographies and referred to continued oversupply. This analyst commentary was included in the supplied text as background around the company’s earlier quarterly performance.

Key numbers at a glance

Why this update matters for investors

The Q4 FY26 update matters because it highlights how exceptional charges can dominate reported profitability even when the top line moves marginally. The figures also show that the company’s FY26 result moved from a profit base in FY25 to a loss in FY26. For investors tracking Tata Chemicals, the split between loss before exceptional items and the reported net loss helps separate operating pressure from one-off or non-operating charges, based on what the company has disclosed.

Any further clarity on segment performance, cash flows, and the path of exceptional items would typically come from detailed filings and management commentary, but only the figures above were provided in the input text.

Conclusion

Tata Chemicals reported March 2026 consolidated net sales of Rs 3,438 crore, down 2.02% YoY, while Q4 FY26 consolidated net loss widened to Rs 2,132 crore amid exceptional charges. The company also reported a consolidated net loss of Rs 1,715 crore for FY26 compared with a profit of Rs 387 crore in FY25. Investors will track subsequent disclosures for more detail on the exceptional charges and how they affect future reported earnings.